Compliance Strategy for Small to Midsized Companies

February 22, 2013

 

Published for Pharmaceutical Compliance Monitor

On Feb. 20, 2013, Jim Hoover’s article, “Compliance Strategy for Small to Midsized Companies,” published in the online version of Pharmaceutical Compliance Monitor. In the article, Jim discusses the basic steps that small to mid-sized pharmaceutical companies should take when conducting an internal investigation. He instructs  companies to carefully consider the scope and limits of the investigation, who should conduct the investigation, how to protect the relevant privileges, and the possible outcomes of the investigation, prior to conducting the investigation. By fully considering these factors, Jim suggests that companies will be in a better position to correct any problems identified and determine whether or not self-disclosure is warranted. For the full article, please click here.  





Legal Disclaimer:
No representation is made that the quality of services to be performed is greater than the quality of legal services performed by other lawyers.

Featured Attorneys

send article

TESTIMONIALS

  • “Their knowledge of the industry and ability to work with borrower's counsel in a number of difficult situations has been invaluable. The firm is very knowledgeable and brings a wealth of experience across multiple practices and disciplines. This provides a strong one-stop shopping experience when working with the firm.”

    -Chambers 2012

  • "A great lawyer: she is practical. When you work on a deal she will protect the client and do it right, but won't waste time on unnecessary issues."

    -Chambers 2013

  • “She’s on my shortlist of lawyers I like working with. She’s very practical and does a lot of retail work and banking work.”

    -Chambers 2012

  • “Melinda Sellers has provided a high level of service to our company. She provides thorough research, high level of organization to any matter, and persuasive legal writing. She has a bright legal career ahead of her.”

    -Chambers 2012

  • "Very good."

    -Chambers 2012